These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23394455)

  • 1. Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset.
    Kano O; Iwamoto K; Ito H; Kawase Y; Cridebring D; Ikeda K; Iwasaki Y
    BMC Neurol; 2013 Feb; 13():19. PubMed ID: 23394455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic pathway in amyotrophic lateral sclerosis.
    Iwasaki Y; Ikeda K; Kinoshita M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):123-6. PubMed ID: 11771767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis in ALS: the problem continues.
    Nzwalo H; de Abreu D; Swash M; Pinto S; de Carvalho M
    J Neurol Sci; 2014 Aug; 343(1-2):173-5. PubMed ID: 24972820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs.
    Galvin M; Ryan P; Maguire S; Heverin M; Madden C; Vajda A; Normand C; Hardiman O
    PLoS One; 2017; 12(6):e0179796. PubMed ID: 28640860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.
    Turner MR; Scaber J; Goodfellow JA; Lord ME; Marsden R; Talbot K
    J Neurol Sci; 2010 Jul; 294(1-2):81-5. PubMed ID: 20452624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
    Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.
    Williams JR; Fitzhenry D; Grant L; Martyn D; Kerr DA
    BMC Neurol; 2013 Nov; 13():160. PubMed ID: 24499173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment pathways in ALS: a South American perspective.
    Dubrovsky AL; Sica RE
    Neurology; 1999; 53(8 Suppl 5):S11-6. PubMed ID: 10560631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Course of Amyotrophic Lateral Sclerosis according to Initial Symptoms: An Analysis of 500 Cases.
    Lee JW; Kang SW; Choi WA
    Yonsei Med J; 2021 Apr; 62(4):338-343. PubMed ID: 33779087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment pathways in ALS: a European perspective.
    Dengler R
    Neurology; 1999; 53(8 Suppl 5):S4-10; discussion S20-1. PubMed ID: 10560630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic interval in amyotrophic lateral sclerosis.
    Iwasaki Y; Ikeda K; Ichikawa Y; Igarashi O; Kinoshita M
    Clin Neurol Neurosurg; 2002 May; 104(2):87-9. PubMed ID: 11932036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow, slurred speech as an initial complaint in amyotrophic lateral sclerosis.
    Tsunoda K; Takazawa M; Chong T; Morita Y
    Auris Nasus Larynx; 2019 Apr; 46(2):193-195. PubMed ID: 30120006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical polymorphism of amyotrophic lateral sclerosis].
    Kovrazhkina EA; Razinskaya OD; Gubsky LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):4-10. PubMed ID: 28884711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis.
    He Z; Sun B; Feng F; Bai J; Wang H; Wang H; Yang F; Cui F; Huang X
    Neurol Sci; 2022 Mar; 43(3):1817-1822. PubMed ID: 34383162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
    Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
    Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms.
    Makkonen T; Ruottinen H; Puhto R; Helminen M; Palmio J
    Int J Lang Commun Disord; 2018 Mar; 53(2):385-392. PubMed ID: 29159848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic factors affecting diagnostic timeline of amyotrophic lateral sclerosis: a 15-year retrospective study.
    Fang T; Pacut P; Bose A; Sun Y; Gao J; Sivakumar S; Bloom B; Nascimento Andrade EI; Trombetta B; Ghasemi M
    Neurol Res; 2024 Sep; 46(9):859-867. PubMed ID: 38825034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression in amyotrophic lateral sclerosis: predictors of survival.
    Magnus T; Beck M; Giess R; Puls I; Naumann M; Toyka KV
    Muscle Nerve; 2002 May; 25(5):709-714. PubMed ID: 11994965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.